Key features of candesartan application in clinical practice

Евдокимова, А. Г.; Lozhkina, M.V.; Коваленко, Е. В.

doi:10.26442/2075-1753_2016.1.54-59

2016

DOI: 10.26442/2075-1753_2016.1.54-59

|View full text |Cite

Key features of candesartan application in clinical practice

А. Г. Евдокимова¹,

M.V. Lozhkina²,

Е. В. Коваленко³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2022

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Effects of angiotensin II receptor blockers on the course of the disease in patients with stable ischemic heart disease

Кочергина

Кочергин

2022

Kompleks. probl. serdečno-sosud. zabol.

View full text Add to dashboard Cite

Highlights. The review synthesizes the results of clinical studies on the use of sartans. This topic is highly relevant due to the antihypertensive, metabolic and organ-protective effect of sartans, which can positively affect the course of coronary atherosclerosis.Abstract. Angiotensin II receptor blockers (sartans) are widely used to treat cardiovascular diseases. This class of drugs has antihypertensive and metabolic effects and organ-protective capabilities. Currently, sartans are of high interest due to their pleiotropic effect: improved lipid metabolism, antidiabetogenic action, nephroprotection, and, as a result, reduced total cardiovascular risk. The article presents an overview of clinical data on the use of sartans in patients with ischemic heart disease, the mechanisms of organ-protective effects and prospects of using this class of drugs for total cardiovascular risk reduction. The following data sources were used: e-Library, ClinicalTrials.gov, PubMed, trialbulletin.com, smartpatients.com, BioPortfolio.com.

show abstract

Effects of angiotensin II receptor blockers on the course of the disease in patients with stable ischemic heart disease

Кочергина

Кочергин

2022

Kompleks. probl. serdečno-sosud. zabol.

View full text Add to dashboard Cite

show abstract

Candesartan in Cardiology Practice

Джаиани

2017

Med. sov.

View full text Add to dashboard Cite

N.A. DZHAIANI, MD, Prof., Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, MoH RF CANDESARTAN IN CARDIOLOGY PRACTICEThe most significant risk factor for the development of cardiovascular diseases such as myocardial infarction, ischemic heart disease, chronic heart failure, is arterial hypertension (AH).[1] AH also contributes to the development of cerebrovascular pathology (ischemic or hemorrhagic stroke, transient ischemic attack) and kidney diseases (chronic kidney disease).

show abstract

Candesartan in Cardiology Practice

Джаиани

2017

Medicinskij sovet

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Key features of candesartan application in clinical practice

Cited by 3 publications

References 0 publications

Effects of angiotensin II receptor blockers on the course of the disease in patients with stable ischemic heart disease

Effects of angiotensin II receptor blockers on the course of the disease in patients with stable ischemic heart disease

Candesartan in Cardiology Practice

Candesartan in Cardiology Practice

Contact Info

Product

Resources

About